NEW INDICATORS OF HSP27 FUNCTIONAL STATE IN BREAST CANCER CELLS WITH DIFFERENT VARIANTS OF HER2/NEU-STATUS

NEW INDICATORS OF HSP27 FUNCTIONAL STATE IN BREAST CANCER CELLS WITH DIFFERENT VARIANTS OF HER2/NEU-STATUS

New and original values (coefficient of phosphorylation and coefficient of intracellular distribution) proposed. They are reflecting a functional state of the heat shock protein 27 kDa (Hsp27) in tumor cells of breast cancer. These coefficients are more clearly reflect the functional state of Hsp27,...

Full description

Bibliographic Details
Main Authors:	E. V. Kaigorodova, M. V. Bogatyuk, M. V. Zavyalova, N. A. Tarabanovskaya, E. I. Simolina, E. M. Slonimskaya, E. L. Choynzonov, V. M. Perelmuter
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2016-02-01
Series:	Сибирский онкологический журнал
Subjects:	рак молочной железы игх hsp27 her2/neu fish cerb2/neu
Online Access:	https://www.siboncoj.ru/jour/article/view/107

Similar Items

Immunogistokhimicheskoe opredelenie ekspressii HER2/neu pri rake molochnoy zhelezy (po dannym Smolenskogo oblastnogo onkologicheskogo klinicheskogo dispansera)
by: O A Shisterova, et al.
Published: (2007-03-01)

Matricsins 2, 7 and 9 in breast tumors. determination of posibile connection with the concentration of HER-2/neu
by: O M Kuznetsova, et al.
Published: (2011-09-01)

Possibilities of predicting the HER2 / neu status in a primary tumor in breast cancer patients using <sup>99m</sup>Tc-DARPinG3
by: O. D. Bragina, et al.
Published: (2023-01-01)

Immunohistochemical characteristics of breast cancer, increasing the risk of local reccurence after organosaving treatment
by: S. M. Demidov, et al.
Published: (2018-10-01)

The development of a highly specific radiochemical compound based on labeled 99mtc recombinant molecules for targeted imaging of cells with the overexpression of Her-2 / neu
by: Olga D. Bragina, et al.
Published: (2017-10-01)

Avaliação digital comparativa da expressão tecidual da proteína cerbB-2 em mulheres portadoras de doenças tumorais da mama Comparative digital evaluation of tissue expression of the cerbB-2 protein in women with breast tumoral diseases
by: Renata Kelly de Araújo Veiga, et al.
Published: (2009-04-01)

EVALUATION OF EXTENT OF BREAST CANCER IN A PATIENT WITH HER2/NEU OVEREXPRESSION USING A RADIOPHARMACEUTICAL BASED ON TECHNETIUM-99M-LABELED TARGET MOLECULES (CASE REPORT)
by: O. D. Bragina, et al.
Published: (2021-10-01)

Possibilities of radionuclide diagnostics of Her2-positive breast cancer using technetium-99m-labeled target molecules: the first experience of clinical use
by: O. D. Bragina, et al.
Published: (2021-04-01)

Clinical possibilities of HER2-positive breast cancer diagnosis using alternative scaffold proteins
by: O. D. Bragina, et al.
Published: (2022-10-01)

Effects of HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) on NEU/HER2 overexpressing mammary tumours in MMTV-NEU-NT mice monitored by Magnetic Resonance Spectroscopy
by: Rodrigues Loreta M, et al.
Published: (2012-05-01)

Clinical significance of changes in the expression level of markers of surrogate breast cancer subtypes in recurrent and metastatic foci (literature review)
by: Yu. S. Krumin, et al.
Published: (2021-03-01)

Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers
by: Atif Ali Hashmi, et al.
Published: (2018-08-01)

Expression of E- and N-cadherins in tumor in luminal, primary operable breast cancer without Her2/neu overexpression in postmenopausal women as a prognostic factor
by: V. V. Tokmakov, et al.
Published: (2020-12-01)

The influence of functional skewness on prognosis of cancer of mammary gland
by: L. E. Erendeeva, et al.
Published: (2002-03-01)

Expression of Her-2/neu in extrahepatic cholangiocarcinoma
by: Shamekh R, et al.
Published: (2017-02-01)

Clinicopathological Significance and Prognostic Role of Her2neu Protein Expression in Patients with Carcinoma Stomach: A Prospective Study from Northern India
by: Abhilash V. B., et al.
Published: (2023-04-01)

Inter-observer agreement in reporting HER 2 Neu protein over expression by immunohistochemistry
by: Ibrahim Al Haddabi, et al.
Published: (2014-01-01)

Immunohistochemical expression of HER2/neu in colorectal carcinoma in Erbil city, Kurdistan Region
by: Lilav Adel Kamal, et al.
Published: (2019-12-01)

HER-2/neu overexpression in breast cancer
by: Rana S. Aziz, et al.
Published: (2010-10-01)

HETEROGENENOUS EXPRESSION OF MARKERS ASSOCIATED WITN INVASIVE BREAST CANCER
by: N. V. Krakhmal, et al.
Published: (2016-10-01)

Role of HER2neu expression in gastric cancer
by: J S Sukanya, et al.
Published: (2021-01-01)

Role of p53 and Her2/Neu as a prognostic biomarker in breast carcinoma
by: Anamika Gupta, et al.
Published: (2023-01-01)

Study of human epidermal growth factor receptor (HER2/neu) expression in primary colorectal carcinoma in a tertiary care hospital
by: Mousmi Agrawal, et al.
Published: (2021-01-01)

HER2/neu Oncogene and Sensitivity to the DNA-Interactive Drug Doxorubicin
by: Anne Mullin, et al.
Published: (2020-12-01)

cERBB-2/Her-2 Neu Overexpression and Prognostic Significance in Uterine Carcinosarcoma
by: Huseyin Salih SEMIZ, et al.
Published: (2023-01-01)

CYTOKINE GENE EXPRESSION ASSOCIATED WITH TUMOR AND PREMETASTATIC NICHES IN BREAST CANCER STROMA
by: L. A. Tashireva, et al.
Published: (2016-12-01)

EGFR and HER2neu Expression in Gall Bladder Carcinoma and Its Association with Clinicopathological Parameters - An Institutional Experience from North India
by: Inara Abeer, et al.
Published: (2021-03-01)

Breast Cancer in Kirkuk City, Hormone Receptors Status (Estrogen and Progesterone) and Her-2/Neu and Their Correlation with Other Pathologic Prognostic Variables
by: Mahmoud Mohammed Mahmoud
Published: (2019-11-01)

Breast Cancer in Kirkuk City, Hormone Receptors Status (Estrogen and Progesterone) and Her-2/Neu and Their Correlation with Other Pathologic Prognostic Variables
by: Mahmoud Mohammed Mahmoud
Published: (2019-11-01)

HER-2/neu expression in lesions of uterine cervix: Is it reliable and consistent?
by: Gupta Nidhi, et al.
Published: (2009-10-01)

Regression of metastatic, radiation/chemotherapy-resistant uterine serous carcinoma overexpressing HER2/neu with trastuzumab emtansine (TDM-1)
by: Alessandro D. Santin, et al.
Published: (2017-02-01)

Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity—From Bench to Bedside
by: Mattan Levi, et al.
Published: (2020-12-01)

HER-2/NEU Ekspresyonun Saptanmasinda İmmunohistokimyasal ve Fish Yöntemi Arasında Diskordansin Belirlenmesi Önemli midir?
by: Berna Bozkurt DUMAN, et al.
Published: (2014-07-01)

Change in HER-2/neu Status from Negative to Positive following Treatment in Breast Cancer: A Case Report
by: Lakshmi Sivarajan, et al.
Published: (2011-01-01)

Correlation of histological grade with Estrogen, Progesterone and HER2/neu reactivity in breast cancer
by: Girishma Shrestha, et al.
Published: (2019-09-01)

PREDICTIVE VALUE OF MOLECULAR PARAMETERS IN PATIENTS WITH BASAL-LIKE TRIPL-NEGATIVE BREAST CANCER
by: О. D. Bragina, et al.
Published: (2016-02-01)

The Study of HER-2/neu, ER/PR Expression Using Immunohistochemistry (IHC) in the Iraqi Breast Cancer
by: Suhad Faisal Hatem, et al.
Published: (2016-06-01)

Target therapy in treatment of HER2-positive breast cancer
by: A. S. Belokhvostova, et al.
Published: (2016-02-01)

LONG-LASTING CONTROL OF HER-2 POSITIVE DISSEMINATED BREAST CANCER IN A REPRODUCTIVE AGED PATIENT
by: A. V. Vazhenin, et al.
Published: (2021-06-01)

Status of estrogene, progesterone receptors and HER-2/neu expression in invasive breast cancer
by: Naghshvar F, et al.
Published: (2007-01-01)